T1	B-Protein	B-Protein	0	16	CholecystokininB	CholecystokininB	B-NP	NN	B-protein	2	NMOD	B-protein
T1	I-Protein	I-Protein	17	25	receptor	receptor	I-NP	NN	I-protein	9	SUB	I-protein
O	O	O	26	30	from	from	B-PP	IN	O	2	NMOD	O
O	O	O	31	36	human	human	B-NP	JJ	B-cell_line	8	NMOD	B-cell_line
O	O	O	37	43	Jurkat	Jurkat	I-NP	NN	I-cell_line	8	NMOD	I-cell_line
O	O	O	44	57	lymphoblastic	lymphoblastic	I-NP	JJ	I-cell_line	8	NMOD	I-cell_line
O	O	O	58	59	T	T	I-NP	NN	I-cell_line	8	NMOD	I-cell_line
O	O	O	60	65	cells	cell	I-NP	NNS	I-cell_line	3	PMOD	I-cell_line
O	O	O	66	68	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	69	77	involved	involve	I-VP	VBN	O	9	VC	O
O	O	O	78	80	in	in	B-PP	IN	O	10	VMOD	O
O	O	O	81	90	activator	activator	B-NP	NN	B-protein	13	NMOD	B-protein
O	O	O	91	98	protein	protein	I-NP	NN	I-protein	19	NMOD	I-protein
O	O	O	98	99	-	-	B-NP	HYPH	O	19	NMOD	O
O	O	O	99	100	1	1	I-NP	CD	O	19	NMOD	O
O	O	O	100	101	-	-	I-NP	HYPH	O	19	NMOD	O
O	O	O	101	111	responsive	responsive	I-NP	JJ	O	19	NMOD	O
O	O	O	112	116	gene	gene	I-NP	NN	O	19	NMOD	O
O	O	O	117	127	activation	activation	I-NP	NN	O	11	PMOD	O
O	O	O	127	128	.	.	O	.	O	9	P	O

O	O	O	130	133	The	The	B-NP	DT	O	2	NMOD	O
O	O	O	134	137	aim	aim	I-NP	NN	O	6	SUB	O
O	O	O	138	140	of	of	B-PP	IN	O	2	NMOD	O
O	O	O	141	145	this	this	B-NP	DT	O	5	NMOD	O
O	O	O	146	151	study	study	I-NP	NN	O	3	PMOD	O
O	O	O	152	155	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	156	158	to	to	B-VP	TO	O	8	VMOD	O
O	O	O	159	166	analyze	analyze	I-VP	VB	O	6	PRD	O
O	O	O	167	170	the	the	B-NP	DT	O	10	NMOD	O
O	O	O	171	175	role	role	I-NP	NN	O	8	OBJ	O
O	O	O	176	178	of	of	B-PP	IN	O	10	NMOD	O
T16	B-Entity	B-Entity	179	194	cholecystokinin	cholecystokinin	B-NP	NN	O	19	NMOD	O
T2	B-Protein	B-Protein	195	196	(	(	O	(	O	18	DEP	O
T2	I-Protein	I-Protein	196	199	CCK	CCK	B-NP	NN	O	18	DEP	O
T2	I-Protein	I-Protein	199	200	(	(	O	(	O	17	DEP	O
T2	I-Protein	I-Protein	200	201	B	B	B-NP	NN	O	17	DEP	O
T2	I-Protein	I-Protein	201	202	)	)	O	)	O	14	NMOD	O
T2	I-Protein	I-Protein	202	203	)	)	O	)	O	12	NMOD	O
T2	I-Protein	I-Protein	204	212	receptor	receptor	B-NP	NN	O	11	PMOD	O
O	O	O	213	215	in	in	B-PP	IN	O	19	NMOD	O
O	O	O	216	221	human	human	B-NP	JJ	B-cell_line	25	NMOD	B-cell_line
O	O	O	222	235	lymphoblastic	lymphoblastic	I-NP	JJ	I-cell_line	25	NMOD	I-cell_line
O	O	O	236	242	Jurkat	Jurkat	I-NP	NN	I-cell_line	25	NMOD	I-cell_line
O	O	O	243	244	T	T	I-NP	NN	I-cell_line	25	NMOD	I-cell_line
O	O	O	245	250	cells	cell	I-NP	NNS	I-cell_line	20	PMOD	I-cell_line
O	O	O	250	251	.	.	O	.	O	6	P	O

O	O	O	252	254	We	We	B-NP	PRP	O	2	SUB	O
O	O	O	255	267	investigated	investigate	B-VP	VBD	O	0	ROOT	O
O	O	O	268	271	the	the	B-NP	DT	O	5	NMOD	O
O	O	O	272	279	trophic	trophic	I-NP	JJ	O	5	NMOD	O
O	O	O	280	286	effect	effect	I-NP	NN	O	2	OBJ	O
O	O	O	287	296	resulting	result	B-VP	VBG	O	5	NMOD	O
O	O	O	297	301	from	from	B-PP	IN	O	6	VMOD	O
O	O	O	302	312	activation	activation	B-NP	NN	O	7	PMOD	O
O	O	O	313	315	of	of	B-PP	IN	O	8	NMOD	O
O	O	O	316	320	such	such	B-NP	JJ	O	12	NMOD	O
O	O	O	321	322	a	a	I-NP	DT	O	12	NMOD	O
O	O	O	323	331	receptor	receptor	I-NP	NN	O	9	PMOD	O
O	O	O	332	334	by	by	B-PP	IN	O	2	VMOD	O
O	O	O	335	340	using	use	B-VP	VBG	O	13	PMOD	O
O	O	O	341	344	the	the	B-NP	DT	O	18	NMOD	O
T17	B-Entity	B-Entity	345	353	reporter	reporter	I-NP	NN	B-DNA	18	NMOD	B-DNA
T17	I-Entity	I-Entity	354	358	gene	gene	I-NP	NN	I-DNA	18	NMOD	I-DNA
O	O	O	359	367	strategy	strategy	I-NP	NN	O	14	OBJ	O
O	O	O	367	368	.	.	O	.	O	2	P	O

O	O	O	369	372	For	For	B-PP	IN	O	7	VMOD	O
O	O	O	373	377	this	this	B-NP	DT	O	3	NMOD	O
O	O	O	378	385	purpose	purpose	I-NP	NN	O	1	PMOD	O
O	O	O	385	386	,	,	O	,	O	7	P	O
O	O	O	387	389	we	we	B-NP	PRP	O	7	SUB	O
O	O	O	390	401	transiently	transiently	B-ADVP	RB	O	7	VMOD	O
O	O	O	402	413	transfected	transfecte	B-VP	VBD	O	0	ROOT	O
O	O	O	414	420	Jurkat	Jurkat	B-NP	NN	B-cell_line	10	NMOD	B-cell_line
O	O	O	421	422	T	T	I-NP	NN	I-cell_line	10	NMOD	I-cell_line
O	O	O	423	428	cells	cell	I-NP	NNS	I-cell_line	7	OBJ	I-cell_line
O	O	O	429	433	with	with	B-PP	IN	O	7	VMOD	O
O	O	O	434	437	the	the	B-NP	DT	O	15	NMOD	O
O	O	O	438	446	reporter	reporter	I-NP	NN	O	15	NMOD	O
O	O	O	447	454	plasmid	plasmid	I-NP	NN	O	15	NMOD	O
O	O	O	455	456	p	p	I-NP	NN	O	11	PMOD	O
O	O	O	456	457	[	[	O	(	O	19	DEP	O
O	O	O	457	458	(	(	O	(	O	19	DEP	O
O	O	O	458	461	TRE	TRE	B-NP	NN	B-DNA	19	DEP	B-DNA
O	O	O	461	462	)	)	O	)	O	7	VMOD	O
O	O	O	462	463	3	3	B-NP	CD	O	24	NMOD	O
O	O	O	463	464	-	-	I-NP	HYPH	O	24	NMOD	O
O	O	O	464	466	tk	tk	I-NP	NN	O	24	NMOD	O
O	O	O	466	467	-	-	I-NP	HYPH	O	24	P	O
O	O	O	467	470	Luc	Luc	I-NP	NN	B-protein	7	OBJ	B-protein
O	O	O	470	471	]	]	O	)	I-protein	24	NMOD	I-protein
O	O	O	472	475	and	and	O	CC	O	7	VMOD	O
O	O	O	476	481	found	find	B-VP	VBD	O	7	VMOD	O
O	O	O	482	486	that	that	B-SBAR	IN	O	27	VMOD	O
T18	B-Entity	B-Entity	487	490	CCK	CCK	B-NP	NN	B-protein	30	NMOD	B-protein
T18	I-Entity	I-Entity	490	491	-	-	O	HYPH	I-protein	32	SUB	I-protein
T18	I-Entity	I-Entity	491	492	8	8	B-NP	CD	I-protein	30	NMOD	I-protein
O	O	O	493	496	was	be	B-VP	VBD	O	28	SBAR	O
O	O	O	497	501	able	able	B-ADJP	JJ	O	32	PRD	O
O	O	O	502	504	to	to	B-PP	TO	O	38	VMOD	O
O	O	O	505	509	dose	dose	B-NP	NN	O	34	PMOD	O
O	O	O	509	510	-	-	B-NP	HYPH	O	38	P	O
O	O	O	510	521	dependently	dependently	B-ADVP	RB	O	38	VMOD	O
O	O	O	522	528	induce	induce	B-VP	VBP	O	33	AMOD	O
T3	B-Protein	B-Protein	529	539	luciferase	luciferase	B-NP	NN	B-protein	40	NMOD	B-protein
O	O	O	540	550	expression	expression	I-NP	NN	O	38	OBJ	O
O	O	O	551	558	related	related	B-ADJP	JJ	O	40	NMOD	O
O	O	O	559	561	to	to	B-PP	TO	O	41	AMOD	O
T19	B-Entity	B-Entity	562	571	activator	activator	B-NP	NN	B-protein	44	NMOD	B-protein
T19	I-Entity	I-Entity	572	579	protein	protein	I-NP	NN	I-protein	46	NMOD	I-protein
T19	I-Entity	I-Entity	579	580	-	-	B-NP	HYPH	O	46	P	O
T19	I-Entity	I-Entity	580	581	1	1	I-NP	CD	O	52	NMOD	O
O	O	O	582	583	(	(	O	(	O	52	NMOD	O
T20	B-Entity	B-Entity	583	585	AP	AP	O	NN	B-protein	52	NMOD	B-protein
T20	I-Entity	I-Entity	585	586	-	-	O	HYPH	I-protein	50	P	I-protein
T20	I-Entity	I-Entity	586	587	1	1	O	CD	I-protein	52	NMOD	I-protein
O	O	O	587	588	)	)	O	)	O	50	DEP	O
O	O	O	589	599	activation	activation	B-NP	NN	O	42	PMOD	O
O	O	O	600	604	with	with	B-PP	IN	O	52	NMOD	O
O	O	O	605	606	a	a	B-NP	DT	O	56	NMOD	O
O	O	O	607	614	maximal	maximal	I-NP	JJ	O	56	NMOD	O
O	O	O	615	623	response	response	I-NP	NN	O	53	PMOD	O
O	O	O	624	633	identical	identical	B-ADJP	JJ	O	56	NMOD	O
O	O	O	634	636	to	to	B-PP	TO	O	57	AMOD	O
O	O	O	637	641	that	that	B-NP	DT	O	58	PMOD	O
O	O	O	642	650	obtained	obtain	B-VP	VBN	O	59	NMOD	O
O	O	O	651	655	with	with	B-PP	IN	O	60	VMOD	O
O	O	O	656	665	compounds	compound	B-NP	NNS	O	61	PMOD	O
O	O	O	666	671	known	know	B-VP	VBN	O	62	NMOD	O
O	O	O	672	674	to	to	B-VP	TO	O	65	VMOD	O
O	O	O	675	683	activate	activate	I-VP	VB	O	63	VMOD	O
T21	B-Entity	B-Entity	684	686	AP	AP	B-NP	NN	B-protein	69	NMOD	B-protein
T21	I-Entity	I-Entity	686	687	-	-	B-NP	HYPH	I-protein	69	NMOD	I-protein
T21	I-Entity	I-Entity	687	688	1	1	I-NP	CD	I-protein	69	NMOD	I-protein
T21	I-Entity	I-Entity	689	696	complex	complex	I-NP	NN	I-protein	65	OBJ	I-protein
O	O	O	697	698	(	(	O	(	O	103	DEP	O
O	O	O	698	712	quantitatively	quantitatively	B-ADVP	RB	O	78	VMOD	O
O	O	O	712	713	,	,	O	,	O	78	P	O
O	O	O	714	717	the	the	B-NP	DT	O	75	NMOD	O
O	O	O	718	722	same	same	I-NP	JJ	O	75	NMOD	O
O	O	O	723	728	level	level	I-NP	NN	O	78	SUB	O
O	O	O	729	731	of	of	B-PP	IN	O	75	NMOD	O
O	O	O	732	741	induction	induction	B-NP	NN	O	76	PMOD	O
O	O	O	742	745	was	be	B-VP	VBD	O	103	DEP	O
O	O	O	746	754	obtained	obtain	I-VP	VBN	O	78	VC	O
O	O	O	755	759	with	with	B-PP	IN	O	79	VMOD	O
O	O	O	760	761	1	1	B-NP	CD	O	82	AMOD	O
O	O	O	762	764	nM	nM	I-NP	NN	O	91	NMOD	O
O	O	O	765	767	12	12	B-NP	CD	O	82	NMOD	O
O	O	O	767	768	-	-	I-NP	HYPH	O	91	NMOD	O
O	O	O	768	769	O	O	I-NP	NN	O	91	NMOD	O
O	O	O	769	770	-	-	B-NP	HYPH	O	91	NMOD	O
O	O	O	770	790	tetradecanoylphorbol	tetradecanoylphorbol	I-NP	NN	O	91	NMOD	O
O	O	O	790	791	-	-	B-NP	HYPH	O	91	NMOD	O
O	O	O	791	793	13	13	I-NP	CD	O	91	NMOD	O
O	O	O	793	794	-	-	I-NP	HYPH	O	91	NMOD	O
O	O	O	794	801	acetate	acetate	I-NP	NN	O	102	NMOD	O
O	O	O	801	802	,	,	O	,	O	102	P	O
O	O	O	803	806	100	100	B-NP	CD	O	94	AMOD	O
O	O	O	807	813	microM	microM	I-NP	NN	O	95	NMOD	O
O	O	O	814	828	diacylglycerol	diacylglycerol	I-NP	NN	O	102	NMOD	O
O	O	O	828	829	,	,	O	,	O	102	P	O
O	O	O	830	832	or	or	O	CC	O	102	NMOD	O
O	O	O	833	834	4	4	B-NP	CD	O	99	AMOD	O
O	O	O	835	837	nM	nM	I-NP	NN	O	102	NMOD	O
O	O	O	838	847	epidermal	epidermal	I-NP	JJ	O	102	NMOD	O
O	O	O	848	854	growth	growth	I-NP	NN	O	102	NMOD	O
O	O	O	855	861	factor	factor	I-NP	NN	O	80	PMOD	O
O	O	O	861	862	)	)	O	)	O	62	NMOD	O
O	O	O	862	863	.	.	O	.	O	7	P	O

O	O	O	864	867	The	The	B-NP	DT	O	2	NMOD	O
O	O	O	868	879	involvement	involvement	I-NP	NN	O	14	SUB	O
O	O	O	880	882	of	of	B-PP	IN	O	2	NMOD	O
O	O	O	883	886	the	the	B-NP	DT	O	9	NMOD	O
T4	B-Protein	B-Protein	887	890	CCK	CCK	I-NP	NN	B-protein	9	NMOD	B-protein
T4	I-Protein	I-Protein	890	891	(	(	O	(	I-protein	9	NMOD	I-protein
T4	I-Protein	I-Protein	891	892	B	B	B-NP	NN	I-protein	9	NMOD	I-protein
T4	I-Protein	I-Protein	892	893	)	)	O	)	I-protein	9	NMOD	I-protein
T4	I-Protein	I-Protein	894	902	receptor	receptor	B-NP	NN	I-protein	3	PMOD	I-protein
O	O	O	903	905	in	in	B-PP	IN	O	2	NMOD	O
O	O	O	906	910	such	such	B-NP	JJ	O	13	NMOD	O
O	O	O	911	912	a	a	I-NP	DT	O	13	NMOD	O
O	O	O	913	924	stimulation	stimulation	I-NP	NN	O	10	PMOD	O
O	O	O	925	928	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	929	941	demonstrated	demonstrate	I-VP	VBN	O	14	VC	O
O	O	O	942	944	by	by	B-PP	IN	O	15	VMOD	O
O	O	O	945	948	the	the	B-NP	DT	O	19	NMOD	O
O	O	O	949	959	inhibiting	inhibit	I-NP	VBG	O	19	NMOD	O
O	O	O	960	966	effect	effect	I-NP	NN	O	16	PMOD	O
O	O	O	967	969	of	of	B-PP	IN	O	19	NMOD	O
O	O	O	970	973	the	the	B-NP	DT	O	22	NMOD	O
O	O	O	974	983	selective	selective	I-NP	JJ	O	28	NMOD	O
T5	B-Protein	B-Protein	984	987	CCK	CCK	I-NP	NN	B-protein	28	NMOD	B-protein
T5	I-Protein	I-Protein	987	988	(	(	O	(	I-protein	28	NMOD	I-protein
T5	I-Protein	I-Protein	988	989	B	B	B-NP	NN	I-protein	28	NMOD	I-protein
T5	I-Protein	I-Protein	989	990	)	)	O	)	I-protein	28	NMOD	I-protein
T5	I-Protein	I-Protein	991	999	receptor	receptor	B-NP	NN	I-protein	28	NMOD	I-protein
O	O	O	1000	1010	antagonist	antagonist	I-NP	NN	O	29	NMOD	O
O	O	O	1011	1013	PD	PD	I-NP	NN	O	33	NMOD	O
O	O	O	1013	1014	-	-	B-NP	HYPH	O	33	P	O
O	O	O	1014	1017	135	135	I-NP	CD	O	33	NMOD	O
O	O	O	1017	1018	,	,	I-NP	,	O	33	P	O
O	O	O	1018	1021	158	158	I-NP	CD	O	20	PMOD	O
O	O	O	1021	1022	.	.	O	.	O	14	P	O

O	O	O	1023	1027	This	This	B-NP	DT	O	2	NMOD	O
O	O	O	1028	1034	effect	effect	I-NP	NN	O	3	SUB	O
O	O	O	1035	1038	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	1039	1048	confirmed	confirm	I-VP	VBN	O	3	VC	O
O	O	O	1049	1051	in	in	B-PP	IN	O	4	VMOD	O
O	O	O	1052	1055	COS	COS	B-NP	NN	B-cell_line	9	NMOD	B-cell_line
O	O	O	1055	1056	-	-	B-NP	HYPH	I-cell_line	9	NMOD	I-cell_line
O	O	O	1056	1057	7	7	I-NP	CD	I-cell_line	9	NMOD	I-cell_line
O	O	O	1058	1063	cells	cell	I-NP	NNS	I-cell_line	5	PMOD	I-cell_line
O	O	O	1064	1075	transfected	transfecte	B-VP	VBN	O	9	NMOD	O
O	O	O	1076	1080	with	with	B-PP	IN	O	10	VMOD	O
O	O	O	1081	1084	the	the	B-NP	DT	O	13	NMOD	O
O	O	O	1085	1089	cDNA	cDNA	I-NP	NN	B-DNA	11	PMOD	B-DNA
O	O	O	1090	1092	of	of	B-PP	IN	O	13	NMOD	O
T6	B-Protein	B-Protein	1093	1096	CCK	CCK	B-NP	NN	B-protein	19	NMOD	B-protein
T6	I-Protein	I-Protein	1096	1097	(	(	O	(	I-protein	19	NMOD	I-protein
T6	I-Protein	I-Protein	1097	1098	B	B	B-NP	NN	I-protein	19	NMOD	I-protein
T6	I-Protein	I-Protein	1098	1099	)	)	O	)	I-protein	19	NMOD	I-protein
T6	I-Protein	I-Protein	1100	1108	receptor	receptor	B-NP	NN	I-protein	14	PMOD	I-protein
O	O	O	1109	1115	cloned	clone	B-VP	VBN	O	19	NMOD	O
O	O	O	1116	1120	from	from	B-PP	IN	O	20	VMOD	O
O	O	O	1121	1127	Jurkat	Jurkat	B-NP	NN	B-cell_line	24	NMOD	B-cell_line
O	O	O	1128	1129	T	T	I-NP	NN	I-cell_line	24	NMOD	I-cell_line
O	O	O	1130	1135	cells	cell	I-NP	NNS	I-cell_line	21	PMOD	I-cell_line
O	O	O	1135	1136	.	.	O	.	O	3	P	O

O	O	O	1137	1139	To	To	B-VP	TO	O	3	VMOD	O
O	O	O	1140	1146	better	well	I-VP	RBR	O	3	VMOD	O
O	O	O	1147	1157	understand	understand	I-VP	VB	O	18	VMOD	O
O	O	O	1158	1161	the	the	B-NP	DT	O	11	NMOD	O
T22	B-Entity	B-Entity	1162	1164	AP	AP	I-NP	NN	B-protein	7	NMOD	B-protein
T22	I-Entity	I-Entity	1164	1165	-	-	B-NP	HYPH	I-protein	7	P	I-protein
T22	I-Entity	I-Entity	1165	1166	1	1	I-NP	CD	I-protein	11	NMOD	I-protein
O	O	O	1166	1167	-	-	I-NP	HYPH	O	11	NMOD	O
O	O	O	1167	1176	dependent	dependent	I-NP	JJ	O	11	NMOD	O
T7	B-Protein	B-Protein	1177	1187	luciferase	luciferase	I-NP	NN	B-protein	11	NMOD	B-protein
O	O	O	1188	1198	expression	expression	I-NP	NN	O	3	OBJ	O
O	O	O	1199	1201	in	in	B-PP	IN	O	11	NMOD	O
O	O	O	1202	1208	Jurkat	Jurkat	B-NP	NN	B-cell_line	15	NMOD	B-cell_line
O	O	O	1209	1210	T	T	I-NP	NN	I-cell_line	15	NMOD	I-cell_line
O	O	O	1211	1216	cells	cell	I-NP	NNS	I-cell_line	12	PMOD	I-cell_line
O	O	O	1216	1217	,	,	O	,	O	18	P	O
O	O	O	1218	1220	we	we	B-NP	PRP	O	18	SUB	O
O	O	O	1221	1227	tested	test	B-VP	VBD	O	0	ROOT	O
O	O	O	1228	1231	two	two	B-NP	CD	O	21	NMOD	O
O	O	O	1232	1240	specific	specific	I-NP	JJ	O	21	NMOD	O
O	O	O	1241	1251	inhibitors	inhibitor	I-NP	NNS	O	18	OBJ	O
O	O	O	1252	1254	of	of	B-PP	IN	O	21	NMOD	O
T8	B-Protein	B-Protein	1255	1261	serine	serine	B-NP	NN	O	26	NMOD	O
T8	I-Protein	I-Protein	1261	1262	/	/	O	SYM	O	26	P	O
T8	I-Protein	I-Protein	1262	1271	threonine	threonine	B-NP	NN	B-protein	26	NMOD	B-protein
T8	I-Protein	I-Protein	1272	1284	phosphatases	phosphatas	I-NP	NNS	I-protein	31	NMOD	I-protein
T8	I-Protein	I-Protein	1284	1285	-	-	B-NP	SYM	O	26	NMOD	O
T8	I-Protein	I-Protein	1285	1286	1	1	I-NP	CD	O	27	PRD	O
O	O	O	1287	1290	and	and	O	CC	O	31	NMOD	O
T9	B-Protein	B-Protein	1291	1292	-	-	B-NP	HYPH	O	31	NMOD	O
T9	I-Protein	I-Protein	1292	1294	2A	2A	I-NP	NN	O	22	PMOD	O
O	O	O	1294	1295	:	:	O	:	O	18	P	O
O	O	O	1296	1303	okadaic	okadaic	B-NP	JJ	O	34	NMOD	O
O	O	O	1304	1308	acid	acid	I-NP	NN	O	37	NMOD	O
O	O	O	1309	1312	and	and	I-NP	CC	O	37	NMOD	O
O	O	O	1313	1322	calyculin	calyculin	I-NP	NN	O	37	NMOD	O
O	O	O	1323	1324	A	A	I-NP	NN	O	18	VMOD	O
O	O	O	1324	1325	.	.	O	.	O	18	P	O

O	O	O	1326	1331	These	These	B-NP	DT	O	2	NMOD	O
O	O	O	1332	1341	compounds	compound	I-NP	NNS	O	4	SUB	O
O	O	O	1342	1350	strongly	strongly	B-VP	RB	O	4	VMOD	O
O	O	O	1351	1360	increased	increase	I-VP	VBD	O	0	ROOT	O
O	O	O	1361	1364	the	the	B-NP	DT	O	15	NMOD	O
O	O	O	1365	1372	phorbol	phorbol	I-NP	NN	O	15	NMOD	O
O	O	O	1372	1373	-	-	B-NP	HYPH	O	15	NMOD	O
O	O	O	1373	1375	12	12	I-NP	CD	O	12	AMOD	O
O	O	O	1375	1376	-	-	I-NP	HYPH	O	12	P	O
O	O	O	1376	1385	myristate	myristate	I-NP	NN	B-DNA	12	NMOD	B-DNA
O	O	O	1385	1386	-	-	B-NP	HYPH	I-DNA	12	P	I-DNA
O	O	O	1386	1388	13	13	I-NP	CD	I-DNA	15	NMOD	I-DNA
O	O	O	1388	1389	-	-	I-NP	HYPH	O	15	NMOD	O
O	O	O	1389	1396	acetate	acetate	I-NP	NN	O	15	NMOD	O
O	O	O	1397	1405	response	response	I-NP	NN	O	4	OBJ	O
O	O	O	1405	1406	,	,	O	,	O	4	P	O
O	O	O	1407	1414	whereas	whereas	O	IN	O	4	VMOD	O
O	O	O	1415	1417	we	we	B-NP	PRP	O	19	SUB	O
O	O	O	1418	1422	have	have	B-VP	VBP	O	17	SBAR	O
O	O	O	1423	1426	not	not	I-VP	RB	O	19	VMOD	O
O	O	O	1427	1435	observed	observe	I-VP	VBN	O	19	VC	O
O	O	O	1436	1437	a	a	B-NP	DT	O	23	NMOD	O
O	O	O	1438	1450	contribution	contribution	I-NP	NN	O	21	OBJ	O
O	O	O	1451	1453	of	of	B-PP	IN	O	23	NMOD	O
O	O	O	1454	1465	phosphatase	phosphatase	B-NP	NN	O	26	NMOD	O
O	O	O	1466	1476	inhibitors	inhibitor	I-NP	NNS	O	24	PMOD	O
O	O	O	1477	1479	on	on	B-PP	IN	O	23	NMOD	O
O	O	O	1480	1481	a	a	B-NP	DT	O	35	NMOD	O
T23	B-Entity	B-Entity	1482	1485	CCK	CCK	I-NP	NN	B-protein	30	NMOD	B-protein
T23	I-Entity	I-Entity	1485	1486	-	-	B-NP	HYPH	I-protein	35	NMOD	I-protein
T23	I-Entity	I-Entity	1486	1487	8	8	I-NP	CD	I-protein	30	NMOD	I-protein
O	O	O	1487	1488	-	-	I-NP	HYPH	O	30	P	O
O	O	O	1488	1495	induced	induce	I-NP	VBN	O	35	NMOD	O
T10	B-Protein	B-Protein	1496	1506	luciferase	luciferase	I-NP	NN	B-protein	35	NMOD	B-protein
O	O	O	1507	1515	activity	activity	I-NP	NN	O	27	PMOD	O
O	O	O	1515	1516	.	.	O	.	O	4	P	O

O	O	O	1517	1519	To	To	B-VP	TO	O	2	VMOD	O
O	O	O	1520	1527	confirm	confirm	I-VP	VB	O	18	VMOD	O
O	O	O	1528	1532	that	that	B-SBAR	IN	O	2	VMOD	O
T11	B-Protein	B-Protein	1533	1536	CCK	CCK	B-NP	NN	B-protein	8	NMOD	B-protein
T11	I-Protein	I-Protein	1536	1537	(	(	O	(	I-protein	8	NMOD	I-protein
T11	I-Protein	I-Protein	1537	1538	B	B	B-NP	NN	I-protein	8	NMOD	I-protein
T11	I-Protein	I-Protein	1538	1539	)	)	O	)	I-protein	8	NMOD	I-protein
T11	I-Protein	I-Protein	1540	1549	receptors	receptor	B-NP	NNS	I-protein	9	SUB	I-protein
O	O	O	1550	1553	are	be	B-VP	VBP	O	3	SBAR	O
O	O	O	1554	1562	involved	involve	I-VP	VBN	O	9	VC	O
O	O	O	1563	1565	in	in	B-PP	IN	O	10	VMOD	O
T24	B-Entity	B-Entity	1566	1568	AP	AP	B-NP	NN	B-protein	15	NMOD	B-protein
T24	I-Entity	I-Entity	1568	1569	-	-	B-NP	HYPH	I-protein	15	NMOD	I-protein
T24	I-Entity	I-Entity	1569	1570	1	1	I-NP	CD	I-protein	15	NMOD	I-protein
O	O	O	1571	1579	response	response	I-NP	NN	O	11	PMOD	O
O	O	O	1579	1580	,	,	O	,	O	18	P	O
O	O	O	1581	1583	we	we	B-NP	PRP	O	18	SUB	O
O	O	O	1584	1596	investigated	investigate	B-VP	VBD	O	0	ROOT	O
O	O	O	1597	1600	the	the	B-NP	DT	O	23	NMOD	O
T25	B-Entity	B-Entity	1601	1604	CCK	CCK	I-NP	NN	B-protein	23	NMOD	B-protein
T25	I-Entity	I-Entity	1604	1605	-	-	O	HYPH	O	23	NMOD	O
T25	I-Entity	I-Entity	1605	1606	8	8	B-NP	CD	O	23	NMOD	O
O	O	O	1607	1613	effect	effect	I-NP	NN	O	18	OBJ	O
O	O	O	1614	1616	on	on	B-PP	IN	O	23	NMOD	O
T12	B-Protein	B-Protein	1617	1628	interleukin	interleukin	B-NP	NN	B-protein	28	NMOD	B-protein
T12	I-Protein	I-Protein	1628	1629	-	-	O	HYPH	I-protein	28	NMOD	I-protein
T12	I-Protein	I-Protein	1629	1630	2	2	B-NP	CD	I-protein	28	NMOD	I-protein
O	O	O	1631	1641	expression	expression	I-NP	NN	O	31	NMOD	O
O	O	O	1641	1642	,	,	O	,	O	31	P	O
O	O	O	1643	1644	a	a	B-NP	DT	O	31	NMOD	O
O	O	O	1645	1652	natural	natural	I-NP	JJ	O	24	PMOD	O
T26	B-Entity	B-Entity	1653	1663	endogenous	endogenous	I-NP	JJ	B-DNA	33	NMOD	B-DNA
T26	I-Entity	I-Entity	1664	1668	gene	gene	I-NP	NN	I-DNA	31	NMOD	I-DNA
O	O	O	1669	1678	regulated	regulate	B-VP	VBN	O	31	NMOD	O
O	O	O	1679	1681	by	by	B-PP	IN	O	34	VMOD	O
O	O	O	1682	1689	several	several	B-NP	JJ	O	37	NMOD	O
O	O	O	1690	1697	factors	factor	I-NP	NNS	O	35	PMOD	O
O	O	O	1697	1698	,	,	O	,	O	37	P	O
O	O	O	1699	1708	including	include	B-PP	VBG	O	37	NMOD	O
T27	B-Entity	B-Entity	1709	1711	AP	AP	B-NP	NN	B-protein	41	NMOD	B-protein
T27	I-Entity	I-Entity	1711	1712	-	-	B-NP	HYPH	I-protein	39	PMOD	I-protein
T27	I-Entity	I-Entity	1712	1713	1	1	I-NP	CD	I-protein	41	NMOD	I-protein
O	O	O	1713	1714	.	.	O	.	O	18	P	O

O	O	O	1715	1717	In	In	B-PP	IN	O	0	ROOT	O
O	O	O	1718	1724	Jurkat	Jurkat	B-NP	NN	B-cell_line	4	NMOD	B-cell_line
O	O	O	1725	1726	T	T	I-NP	NN	I-cell_line	4	NMOD	I-cell_line
O	O	O	1727	1732	cells	cell	I-NP	NNS	I-cell_line	1	PMOD	I-cell_line
O	O	O	1733	1742	activated	activate	B-VP	VBN	O	4	NMOD	O
O	O	O	1743	1745	by	by	B-PP	IN	O	5	VMOD	O
O	O	O	1746	1753	phorbol	phorbol	B-NP	NN	O	17	NMOD	O
O	O	O	1753	1754	-	-	B-NP	HYPH	O	17	NMOD	O
O	O	O	1754	1756	12	12	I-NP	CD	O	13	NMOD	O
O	O	O	1756	1757	-	-	I-NP	HYPH	O	13	P	O
O	O	O	1757	1766	myristate	myristate	I-NP	NN	B-DNA	13	NMOD	B-DNA
O	O	O	1766	1767	-	-	B-NP	HYPH	I-DNA	13	P	I-DNA
O	O	O	1767	1769	13	13	I-NP	CD	I-DNA	17	NMOD	I-DNA
O	O	O	1769	1770	-	-	I-NP	HYPH	O	17	NMOD	O
O	O	O	1770	1777	acetate	acetate	I-NP	NN	O	17	NMOD	O
O	O	O	1778	1781	and	and	I-NP	CC	O	17	NMOD	O
T13	B-Protein	B-Protein	1782	1800	phytohemagglutinin	phytohemagglutinin	I-NP	NN	B-protein	26	NMOD	B-protein
O	O	O	1800	1801	,	,	O	,	O	20	P	O
T28	B-Entity	B-Entity	1802	1805	CCK	CCK	B-NP	NN	B-protein	20	NMOD	B-protein
T28	I-Entity	I-Entity	1805	1806	-	-	B-NP	HYPH	I-protein	17	NMOD	I-protein
T28	I-Entity	I-Entity	1806	1807	8	8	I-NP	CD	I-protein	20	AMOD	I-protein
O	O	O	1808	1815	induced	induce	I-NP	VBN	O	26	NMOD	O
T14	B-Protein	B-Protein	1816	1818	IL	IL	I-NP	NN	B-protein	26	NMOD	B-protein
T14	I-Protein	I-Protein	1818	1819	-	-	O	HYPH	I-protein	26	NMOD	I-protein
T14	I-Protein	I-Protein	1819	1820	2	2	B-NP	CD	I-protein	26	NMOD	I-protein
O	O	O	1821	1831	expression	expression	I-NP	NN	O	6	PMOD	O
O	O	O	1831	1832	.	.	O	.	O	1	P	O

O	O	O	1833	1837	This	This	B-NP	DT	O	2	NMOD	O
O	O	O	1838	1847	induction	induction	I-NP	NN	O	3	SUB	O
O	O	O	1848	1851	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	1852	1861	abolished	abolish	I-VP	VBN	O	3	VC	O
O	O	O	1862	1864	by	by	B-PP	IN	O	4	VMOD	O
O	O	O	1865	1867	PD	PD	B-NP	NN	O	10	NMOD	O
O	O	O	1867	1868	-	-	B-NP	HYPH	O	10	NMOD	O
O	O	O	1868	1871	135	135	I-NP	CD	O	10	NMOD	O
O	O	O	1871	1872	,	,	I-NP	,	O	10	P	O
O	O	O	1872	1875	158	158	I-NP	CD	O	5	PMOD	O
O	O	O	1875	1876	.	.	O	.	O	3	P	O

O	O	O	1877	1880	Our	Our	B-NP	PRP$	O	2	NMOD	O
O	O	O	1881	1888	results	result	I-NP	NNS	O	3	SUB	O
O	O	O	1889	1897	indicate	indicate	B-VP	VBP	O	0	ROOT	O
O	O	O	1898	1902	that	that	B-SBAR	IN	O	3	VMOD	O
T29	B-Entity	B-Entity	1903	1906	CCK	CCK	B-NP	NN	B-protein	8	SUB	B-protein
T29	I-Entity	I-Entity	1906	1907	-	-	O	HYPH	O	8	P	O
T29	I-Entity	I-Entity	1907	1908	8	8	B-NP	CD	O	8	NMOD	O
O	O	O	1909	1915	exerts	exert	I-NP	NNS	O	11	NMOD	O
O	O	O	1916	1917	a	a	B-NP	DT	O	11	NMOD	O
O	O	O	1918	1925	trophic	trophic	I-NP	JJ	O	11	NMOD	O
O	O	O	1926	1932	effect	effect	I-NP	NN	O	4	SBAR	O
O	O	O	1933	1935	in	in	B-PP	IN	O	11	NMOD	O
O	O	O	1936	1942	Jurkat	Jurkat	B-NP	NN	B-cell_line	15	NMOD	B-cell_line
O	O	O	1943	1944	T	T	I-NP	NN	I-cell_line	15	NMOD	I-cell_line
O	O	O	1945	1950	cells	cell	I-NP	NNS	I-cell_line	12	PMOD	I-cell_line
O	O	O	1951	1958	through	through	B-PP	IN	O	11	NMOD	O
O	O	O	1959	1970	stimulation	stimulation	B-NP	NN	O	16	PMOD	O
O	O	O	1971	1973	of	of	B-PP	IN	O	17	NMOD	O
T15	B-Protein	B-Protein	1974	1977	CCK	CCK	B-NP	NN	B-protein	23	NMOD	B-protein
T15	I-Protein	I-Protein	1977	1978	(	(	O	(	I-protein	23	NMOD	I-protein
T15	I-Protein	I-Protein	1978	1979	B	B	B-NP	NN	I-protein	23	NMOD	I-protein
T15	I-Protein	I-Protein	1979	1980	)	)	O	)	I-protein	23	NMOD	I-protein
T15	I-Protein	I-Protein	1981	1990	receptors	receptor	B-NP	NNS	I-protein	18	PMOD	I-protein
O	O	O	1991	1993	by	by	B-PP	IN	O	17	NMOD	O
O	O	O	1994	2004	modulation	modulation	B-NP	NN	O	24	PMOD	O
O	O	O	2005	2007	of	of	B-PP	IN	O	25	NMOD	O
O	O	O	2008	2018	expression	expression	B-NP	NN	O	26	PMOD	O
O	O	O	2019	2021	of	of	B-PP	IN	O	27	NMOD	O
T30,T31	B-Entity,B-Entity	B-Entity,B-Entity	2022	2024	AP	AP	B-NP	NN	B-DNA	34	NMOD	B-DNA
T30,T31	I-Entity,I-Entity	I-Entity,I-Entity	2024	2025	-	-	B-NP	HYPH	I-DNA	29	P	I-DNA
T30,T31	I-Entity,I-Entity	I-Entity,I-Entity	2025	2026	1	1	I-NP	CD	I-DNA	29	NMOD	I-DNA
T30	I-Entity	I-Entity	2026	2027	-	-	B-NP	HYPH	I-DNA	34	NMOD	I-DNA
T30	I-Entity	I-Entity	2027	2036	regulated	regulate	I-NP	VBN	I-DNA	34	NMOD	I-DNA
T30,T32	I-Entity,B-Entity	I-Entity,B-Entity	2037	2042	genes	gene	I-NP	NNS	I-DNA	28	PMOD	I-DNA
O	O	O	2042	2043	.	.	O	.	O	3	P	O
